A Big Pharma mole looking to destabilize CYDY shareholder base would likely suggest something similar. As well as insinuate management was incapable of "getting across the goal line" when they've done the equivalent of returning a 99 yard punt. As well as float the idea that a buyout would be quick and lucrative for shareholders.

Hell, they might even give themselves a fancy moniker and fantastic backstory like "Doctor Immunologist" or the like.

You know, bush league antics.